<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR147">
 <label>147.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shulman</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Cohen</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Soto-Gutierrez</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Yagi</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Goldwasser</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Lee-Parsons</surname>
    <given-names>CW</given-names>
   </name>
   <name>
    <surname>Benny-Ratsaby</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Yarmush</surname>
    <given-names>ML</given-names>
   </name>
   <name>
    <surname>Nahmias</surname>
    <given-names>Y</given-names>
   </name>
  </person-group>
  <article-title>Enhancement of naringenin bioavailability by complexation with hydroxypropyl-beta-cyclodextrin. [corrected]</article-title>
  <source>PLoS One</source>
  <year>2011</year>
  <volume>6</volume>
  <issue>4</issue>
  <fpage>e18033</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0018033</pub-id>
  <?supplied-pmid 21494673?>
  <pub-id pub-id-type="pmid">21494673</pub-id>
 </element-citation>
</ref>
